Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Chronic kidney disease stages 1-3 increase the risk of venous thrombosis.

Ocak G, Verduijn M, Vossen CY, Lijfering WM, Dekker FW, Rosendaal FR, Gansevoort RT, Mahmoodi BK.

J Thromb Haemost. 2010 Nov;8(11):2428-35. doi: 10.1111/j.1538-7836.2010.04048.x.

PMID:
20831624
2.

Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.

Hwang SJ, Lin MY, Chen HC, Hwang SC, Yang WC, Hsu CC, Chiu HC, Mau LW.

Nephrol Dial Transplant. 2008 Oct;23(10):3192-8. doi: 10.1093/ndt/gfn222. Epub 2008 May 1.

3.

Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.

Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW.

Nephron Clin Pract. 2007;107(4):c177-81. Epub 2007 Nov 1.

PMID:
17975325
4.

Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.

Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R.

J Hypertens. 2010 Jan;28(1):156-62. doi: 10.1097/HJH.0b013e328332038c.

PMID:
19915481
5.

The unrecognized prevalence of chronic kidney disease in diabetes.

Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, Kalra PA, O'Donoghue DJ, New JP.

Nephrol Dial Transplant. 2006 Jan;21(1):88-92. Epub 2005 Oct 12.

6.

Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.

Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, Hayashi K, Ishiki R, Takeichi Y, Iwase M, Inagaki H, Murohara T.

Am Heart J. 2009 Jul;158(1):92-8. doi: 10.1016/j.ahj.2009.04.013.

PMID:
19540397
7.

Cardiorenal risk factors.

Wall BM.

Am J Med Sci. 2010 Jul;340(1):25-9. doi: 10.1097/MAJ.0b013e3181e59078. Review.

PMID:
20610968
8.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.

Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.

Ren Fail. 2008;30(6):625-8. doi: 10.1080/08860220802134607.

PMID:
18661413
9.

Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.

Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D.

Adv Chronic Kidney Dis. 2007 Jan;14(1):105-12.

PMID:
17200050
10.

Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.

Nephrology (Carlton). 2008 Jun;13(3):242-6. doi: 10.1111/j.1440-1797.2007.00898.x. Epub 2008 Jan 23.

PMID:
18221258
11.

[Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].

Grabysa R, Cholewa M.

Pol Merkur Lekarski. 2008 Jun;24(144):487-91. Polish.

PMID:
18702327
12.

Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke.

Ovbiagele B.

Arch Neurol. 2008 Jul;65(7):934-8. doi: 10.1001/archneur.65.7.934.

PMID:
18625861
13.

Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Inoue T, Iseki K, Iseki C, Ohya Y, Kinjo K, Takishita S.

Clin Exp Nephrol. 2009 Oct;13(5):487-93. doi: 10.1007/s10157-009-0193-3. Epub 2009 May 15.

PMID:
19444548
14.

Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS Cohort Study.

McClellan WM, Newsome BB, McClure LA, Cushman M, Howard G, Audhya P, Abramson JL, Warnock DG.

Am J Nephrol. 2009;29(1):10-7. doi: 10.1159/000148645. Epub 2008 Jul 26.

15.

Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.

Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.

Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S86-99. doi: 10.1053/j.ajkd.2008.07.052.

PMID:
19231766
16.

Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.

Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD.

Circulation. 2004 Dec 14;110(24):3667-73. Epub 2004 Nov 29.

17.

Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.

Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE.

Nephrol Dial Transplant. 2006 May;21(5):1257-62. Epub 2006 Jan 18.

18.

Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality.

Na SY, Sung JY, Chang JH, Kim S, Lee HH, Park YH, Chung W, Oh KH, Jung JY.

Am J Nephrol. 2011;33(2):121-30. doi: 10.1159/000323740. Epub 2011 Jan 14.

PMID:
21242672
19.

Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice.

New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, O'Donoghue DJ.

Diabet Med. 2007 Apr;24(4):364-9. Epub 2007 Feb 28.

20.

Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.

Lorenzen J, Krämer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT.

Eur J Clin Invest. 2010 Apr;40(4):294-300. doi: 10.1111/j.1365-2362.2010.02271.x.

PMID:
20486990
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk